These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4311844)

  • 1. Inhibition of Friend virus-induced splenomegaly by an associated lymphatic leukemia virus.
    Dawson PJ; Fieldsteel AH
    Proc Soc Exp Biol Med; 1969 Dec; 132(3):898-901. PubMed ID: 4311844
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex.
    Steeves RA; Eckner RJ; Bennett M; Mirand EA; Trudel PJ
    J Natl Cancer Inst; 1971 Jun; 46(6):1209-17. PubMed ID: 4325930
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Friend leukemia virus splenomegaly by an acetylenic carbamate.
    DeLong DC; Baker LA; Easton NR; Dillard RD
    Proc Soc Exp Biol Med; 1968 Mar; 127(3):845-9. PubMed ID: 5651144
    [No Abstract]   [Full Text] [Related]  

  • 4. A new virus of minimal pathogenicity associated with Friend virus. I. Isolation by end-point dilution.
    Rowson KE; Parr IB
    Int J Cancer; 1970 Jan; 5(1):96-102. PubMed ID: 4313234
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of Friend and Rauscher leukemia virus replication in mice by Guaroa virus.
    Turner W; Chirigos MA; Scott D
    Cancer Res; 1968 Jun; 28(6):1064-73. PubMed ID: 5658440
    [No Abstract]   [Full Text] [Related]  

  • 6. INTERRELATION BETWEEN THE TRANSPLANTABLE FRIEND VIRUS LEUKEMIA TUMOR AND SPLENOMEGALY IN DD MICE.
    NAGAI K; TSURU T
    Med J Osaka Univ; 1964 Dec; 15():203-7. PubMed ID: 14315913
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection.
    Sidwell RW; Dixon GJ; Compton P; Schabel FM
    Cancer Res; 1969 Mar; 29(3):497-502. PubMed ID: 5773795
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of sensitization with bacterial antigens on the replication of Friend spleen focus-forming virus.
    Flickinger JT; Gentile JM
    Can J Microbiol; 1971 Apr; 17(4):481-6. PubMed ID: 5553350
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice.
    Sidwell RW; Allen LB; Huffman JH; Witkowski JT; Sinon LN
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):854-8. PubMed ID: 1129309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of antibodies against salmonella lipopolysaccharides during a latent infection by Friend murine leukemia virus.
    Ransom JP; Gorman JM; Tulve S
    Cancer Res; 1969 Jul; 29(7):1407-15. PubMed ID: 5799159
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Friend disease of double-stranded RNA of fungal origin.
    Pilch DJ; Planterose DN
    J Gen Virol; 1971 Feb; 10(2):155-62. PubMed ID: 5553709
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of erythroid target cells for Friend murine leukemia virus by intravenous pyran treatment.
    Schuller GB; Morahan PS
    J Natl Cancer Inst; 1979 May; 62(5):1257-60. PubMed ID: 286101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of Friend virus leukemia by leucogenenol.
    Elliott SC; Jacoby AN; Barnhill MA; Howard WE
    J Natl Cancer Inst; 1973 Oct; 51(4):1135-9. PubMed ID: 4542842
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of two strains of Friend murine leukemia viruses differing in ability to induce early splenomegaly: lack of relationship with generation of recombinant mink cell focus-forming viruses.
    Sitbon M; Evans L; Nishio J; Wehrly K; Chesebro B
    J Virol; 1986 Jan; 57(1):389-93. PubMed ID: 3001361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition and enhancement of Friend leukemia virus by pyran copolymer.
    Schuller GB; Morahan PS; Snodgrass M
    Cancer Res; 1975 Aug; 35(8):1915-20. PubMed ID: 1149015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective immunotherapy of Friend virus infection.
    Chirigos MA; March RW; Hook W; Hoemann R
    Proc Soc Exp Biol Med; 1967 May; 125(1):35-7. PubMed ID: 6027552
    [No Abstract]   [Full Text] [Related]  

  • 17. Friend leukemia virus spleen focus assay: relationship of spleen foci to viremia, splenomegaly, and survival time.
    Chirigos MA; Schwalb ED; Scott D
    Cancer Res; 1967 Dec; 27(12):2249-54. PubMed ID: 6082279
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory effect of Friend leukemia virus infection on the antibody formation to sheep erythrocytes in mice.
    Odaka T; Ishi H; Yamaura K; Yamamoto T
    Jpn J Exp Med; 1966 Jun; 36(3):277-90. PubMed ID: 5296558
    [No Abstract]   [Full Text] [Related]  

  • 19. Inheritance of susceptibility to Friend mouse leukemia virus. XI. Genetic control of late splenomegaly.
    Odaka T
    Int J Cancer; 1973 Jul; 12(1):124-8. PubMed ID: 4790703
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation of splenomegaly to depressed liver catalase in Friend virus-infected germfree and conventional mice.
    Price FW; Mirand EA; Grace JT
    Proc Soc Exp Biol Med; 1966 Mar; 121(3):933-7. PubMed ID: 5935617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.